These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 30628518)

  • 1. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
    Yamane MLM; Belsito DV; Glass LRD
    Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial and neck erythema associated with dupilumab treatment: A systematic review.
    Jo CE; Finstad A; Georgakopoulos JR; Piguet V; Yeung J; Drucker AM
    J Am Acad Dermatol; 2021 May; 84(5):1339-1347. PubMed ID: 33428978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
    van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosacea associated with dupilumab therapy.
    Heibel HD; Hendricks AJ; Foshee JP; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
    [No Abstract]   [Full Text] [Related]  

  • 5. A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis.
    Jaros J; Hendricks AJ; Shi VY; Lio PA
    Dermatitis; 2020; 31(3):169-177. PubMed ID: 32355092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab-Induced Extrafacial Paradoxical Persistent Erythema in an Atopic Dermatitis Patient.
    Juan-Carpena G; Palazón-Cabanes JC; Bañuls J; Docampo-Simón A; Sánchez-Pujol MJ; Niveiro M; Silvestre JF
    Dermatitis; 2021 Oct; 32(1S):e83-e85. PubMed ID: 34405837
    [No Abstract]   [Full Text] [Related]  

  • 7. A case series of dupilumab-treated allergic contact dermatitis patients.
    Goldminz AM; Scheinman PL
    Dermatol Ther; 2018 Nov; 31(6):e12701. PubMed ID: 30246906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab for the treatment of adolescents with atopic dermatitis.
    Senner S; Seegräber M; Frey S; Kendziora B; Eicher L; Wollenberg A
    Expert Rev Clin Immunol; 2020 Jul; 16(7):641-650. PubMed ID: 32720530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
    [No Abstract]   [Full Text] [Related]  

  • 10. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema.
    Crepy MN; Nosbaum A; Bensefa-Colas L
    Contact Dermatitis; 2019 Aug; 81(2):145-147. PubMed ID: 30851059
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ocular symptoms associated with dupilumab in atopic dermatitis].
    Voorberg AN; Oosterhaven JAF; Wijdh RHJ; de Bruin-Weller MS; Schuttelaar MLA
    Ned Tijdschr Geneeskd; 2019 Mar; 163():. PubMed ID: 30945835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
    de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
    Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.
    Liberman P; Shifera AS; Berkenstock M
    Cornea; 2020 Jun; 39(6):784-786. PubMed ID: 31985517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular surface disease associated with dupilumab treatment for atopic diseases.
    Utine CA; Li G; Asbell P; Pflugfelder S; Akpek E
    Ocul Surf; 2021 Jan; 19():151-156. PubMed ID: 32439390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of dupilumab-associated conjunctivitis in atopic dermatitis.
    Aszodi N; Thurau S; Seegräber M; de Bruin-Weller M; Wollenberg A
    J Dtsch Dermatol Ges; 2019 May; 17(5):488-491. PubMed ID: 30873757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records.
    Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA
    Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Helper 2 Inhibitors in Allergic Contact Dermatitis.
    Ludwig CM; Krase JM; Shi VY
    Dermatitis; 2021 Jan-Feb 01; 32(1):15-18. PubMed ID: 32496280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angioedema: A potential complication of dupilumab in atopic dermatitis.
    Fritz AL; Lacy FA; Morrell DS
    Pediatr Dermatol; 2021 Jan; 38(1):237-238. PubMed ID: 33099796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab for allergic contact dermatitis and implications for patch testing: Irreconcilable differences.
    Shah P; Milam EC; Lo Sicco KI; Cohen DE
    J Am Acad Dermatol; 2020 Sep; 83(3):e215-e216. PubMed ID: 32417419
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review.
    Raffi J; Suresh R; Botto N; Murase JE
    J Am Acad Dermatol; 2020 Jan; 82(1):132-138. PubMed ID: 31562940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.